Opinion of the Scientific Panel on contaminants in the food chain [CONTAM] related to the safety assessment of wild and farmed fish

EFSA Journal

Volumn 3, Issue 7, 2005, Pages

[No Author Info available]

Author keywords

Baltic herring; beneficial effects; evaluation overview; fish consumption; fish contamination; methylmercury; nutritional composition; PCB; PCDD F; polybrominated flame retardants; quality of feed; wild and farmed fish

Indexed keywords

EID: 85018798557     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2005.236     Document Type: Article

References (335)

1. Adam O. (2004). Influence of n-3 fatty acids on the physiological and pathophysiological immune response in humans. Aktuel Ernaehr Med 29: 178–182.
2. Albert C.M., Campos H., Stampfer M.J., Ridker P.M., Manson J.E., Willett W.C., Ma J. (2002). Blood levels of long-chain n 3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346: 1113–1118.
3. Albert C.M., Hennekens C.H., O'Donnell C.J., Ajani U.A., Carey V.J., Willett W.C., Ruskin J.N., Manson J.E. (1998). Fish consumption and risk of sudden cardiac death. J. Am. Med. Assoc. 279: 23–28.
4. Andersson PL, Wågman N, Berg HA, Olsson P-E, Tysklind M (1999). Biomagnification of structurally matched polychlorinated and polybrominated diphenylethers (PCDE/PBDE) in Zebrafish (Danio rerio). Organohalogen Compounds 43: 9–12.
5. Anonymous. Nordic risk assessment of toxaphene exposure. TemaNord 1997:540, ISBN 92-893-0041-8 (1997).
6. Aidos I., van der Padt A., Luten J.B., Boom R.M. (2002). Seasonal changes in crude and lipid composition of herring fillets, byproducts, and respective produced oils. J. Agric Food Chem 50: 4589–4599.
7. Ascherio A., Rimm E.B., Stampfer M.J., Giovannucci E.L., Willett W.C. (1995). Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N. Engl. J. Med. 332: 977–982.
8. Augustsson K., Michaud D.S., Rimm E.B., Leitzmann M.F., Stampfer M.J., Willett W.C., Giovanucci E. (2003). A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev 12: 64–67.
9. Bakker E.C., Ghys A.J.A., Kester A.D.M., Vles J.S.H., Dubas J.S., Blanco C.E., Hornstra G. (2003). Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 y of age. Eur. J. Clin. Nutr. 57: 89–95.
10. Bakker E.C., Van Houwelingen A.C., Hornstra G. (1999). Early nutrition, essential fatty acid status and visual acuity of term infants at 7 months of age. Eur J Clin Nutr 53: 872–879.
11. Barcelli U., Glas-Grennwalt P., Pollak V.E. (1985). Enhancing effect of dietary supplementation with omega-3 fatty acids on plasma fibrinolysis in normal subjects. Thromb Res 39: 307–312.
12. Bell J.G., McGhee F., Tocher D.R., Dick J.R. (2004). Dioxin and dioxin-like PCB content of farmed salmon flesh, the effect of feeding diets containing marine fish oil or vegetable oils. Proc. 11th ISNFF, Phuket, Thailand: 52.
13. Bell J.G., McEvoy J., Webster J.L., McGhee F., Millar R.M., Sargent J.R. (1998). Flesh lipid and carotenoid composition of Scottish farmed Atlantic salmon (Salmo salar). J Agric Food Chem 46: 119–127.
14. Bergmann S., Neumeister V., Siekmeier R., Mix C., Wahrburg V., Jaross W. (1998). Food supply abundant increase of serum selenium concentrations in middle-aged Dresden women between 1990 and 1996. Toxicol Lett 96/97:181–187.
15. Berntssen MHG, Lundebye A-K, Torstensen B (2005). Reducing the levels of dioxins and dioxin-like PCBs in Atlantic salmon by substitution of fish oil with vegetable oil in the feed. Aquaculture Nutrition 11: 219–231.
16. Berntssen MHG, Hylland K, Julshamn K, Lundebye A-K, Waagbø R (2004). Maximum limits for organic and inorganic mercury in fish feeds. Aquacult. Nutr. 10: 83–97.
17. Berntssen MHG, Aspholm OØ, Hylland K, Wendelaar Bonga SE, Lundebye, A-K (2001). Tissue metallothionein, apoptosis and cell proliferation responses in Atlantic salmon (Salmo salar L.) parr fed elevated dietary cadmium. Comp. Biochem. Physiol. C128: 299–310.
18. Bethune C, Julshamn K, Lundebye A-K (2005). A preliminary comparison of polybrominated diphenyl ethers (PBDEs) to lipid content and levels of polychlorinated biphenyls (PCBs) and dioxins (PCDD/Fs) in farmed Atlantic salmon (Salmo salar). Int. Food Sci. Tech. 40: 143–148.
19. Birch E.E., Birch D.G., Hoffman D.R., Uauy R. (1992 a). Essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 33: 3242–3253.
20. Birch D.G., Birch E.E., Hoffman D.R., Uauy R.D. (1992 b). Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids. Invest Ophthalmol Vis Sci 33: 2365–2376.
21. Bocio A, Llobet JM, Domingo JL, Corbella J, Teixidó A, Casas C (2003). Polybrominated diphenyl ethers (PBDEs) in foodstuffs: human exposure through the diet. Journal of Agricultural and Food Chemistry 51: 3191–3195.
22. Bohl M. (1999). Zucht und Produktion von Süsswasserfischen. 2nd Edition. DLG-Verlag, Frankfurt.
23. Bone Q., Marshall N.B., Blaxter J.H.S. (1995). Biology of fishes. Blackie Academic and professional. Second edition, pp 332.
24. Breivik H, Thorstad O (2004). Removal of organic environmental pollutants from fish oil by short path distilation. The effect of a working fluid. EuroFed Lipid conference, 5–8, September. Edinburgh, U.K.
25. Brzóska M.M. and Moniuszko-Jakoniuk J. (1998). The influence of calcium content in diet on cumulation and toxicity of cadmium in the organism. Arch. Toxicol. 72: 63–73.
26. Brüschweiler B.J., Spriano D., Schlatter J. (2004). Gesundheitliche Risikobewertung der Toxaphen-Rückstände in Lebensmitteln. Mitt. Lebensm. Hyg. 95: 162–189.
27. Burel C., Boujard T., Escaffre A.-M., Kaushik S.J., Boeuf G., Mol K.A., Van den Geyten S., Kühn E.R. (2000). Dietary low-glucosinolate rapeseed meal affects thyroid status and nutrient utilization in rainbow trout (Oncorhynchus mykiss). Brit. J. Nutr. 83: 653–664.
28. Burr M.L., Sweetham P.M., Fehily A.M. (1994). Diet and reinfarction. Eur. Heart J. 15: 1152–1153.
29. Burr ML, Ashfield-Watt PA, Dunstan FD et al. (2003). Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 57: 193–200.
30. Burreau S, Broman D, Örn, U (2000) Tissue distribution of 2, 2′, 4, 4′-tetrabromo[14C]diphenyl ether ([14C]-PBDE 47) in pike (Esox lucius) after dietary exposure – a time series study using whole body autoradiography. Chemosphere 40: 977–985.
31. Burreau S, Axelman J, Broman D, Jakobsson E (1997). Dietary uptake in pike (Esox lucius) of some polychlorinated biphenyls, polychlorinated naphthalenes and polybrominated diphenyl ethers administered in natural diet. Environmental Toxicology and Chemistry 16: 2508–2513.
32. Cahu C., Salen P., De Lorgeril M. (2004). Farmed and wild fish in the prevention of cardiovascular diseases: assessing possible differences in lipid nutritional values. Nutr Metab Cardiovasc Dis 14: 34–41.
33. Cairns J.A., Gill J., Morton B., Roberts R., Gent M., Hirsh J., Holder D., Finnie K., Marquis J.F., Naqvi S., Cohen E. (1996). Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study. Circulation 94: 1553–1560.
34. Calder P.C. (2005). Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans. 33: 423–427.
35. Canfield R.L., Henderson C.R. jr, Cory-Slechta D.A., Cox C., Jusko T.A., Lanphear B.P. (2003). Intellectual impairment in children with blood lead concentrations below 10 microgram per decilitre. N. Eng. J. Med. 348: 1517–1526.
36. Chu I., Villeneuve D.C., Sun C.W., Secours V., Procter B., Arnold E., Clegg D., Reynolds L., Valli V.E. (1986). Toxicity of toxaphene in the rat and beagle dog. Fundam Appl Toxicol 7:406–418.
37. Cincier D.C, Petit-Ramel M, Faure R, Bortolato M (1998). Cadmium accumulation and metallothionein biosynthesis in Cyprinus carpio tissues. Bull. Environ. Contam. Toxicol. 61: 793–9.
38. Claisse D., Cossa D., Bretaudeau-Sanjuan J., Touchard G., Bombled B. (2001). Methylmercury in molluscs along the French coast. Mar Pollut Bull. 42:329–332.
39. Clandinin M.T. (1999). Brain development and assessing the supply of polyunsaturated fatty acids. Lipids 34: 131–137.
40. Clandinin M.T., Chappell J.E., Van Aerde J.E.E. (1989). Requirements of newborn infants for long chain polyunsaturated fatty acids. Acta Paediatr. Scand. S351: 63–71.
41. Clarke J.T., Cullen-Dean G., Regelink E., Chan L., Rose V. (1990). Increased incidence of epistaxis in adolescents with familial hypercholesterolemia treated with fish oil. J Pediatr 116: 139–141.
42. Connor W.E., Lowensohn R., Hatcher L. (1996). Increased docosahexaenoic acid levels in human newborn infants by administration of sardines and fish oil during pregnancy. Lipids 31: S183–S187.
43. Connor W.E., DeFrancesco C.A., Connor S.L. (1993). N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients. Ann NY Acad Sci 638: 16–34.
44. Corraze G., Radunz-Neto J., Richard N., Cardinal M., Kaushik S. (2004). Flesh quality of rainbow trout fed diets containing a blend of vegetable oils over a full cycle. Proc. 11th ISNFF, Phuket, Thailand: 55.
45. Cossa D., Auger D., Averty B., Lucon M., Masselin P., Noel J., San-Juan J. (1989). Atlas des niveaux de concentration en métaux métalloïdes et composés organochlorés dans les produits de la pêche cotière française. Technical Report, IFREMER, Nantes.
46. Danish Fish Assessment (2003). General view of fish and fish products. Danish Food and Veterinary Administration, Moerkhoej, Denmark.
47. Daviglus M.L., Stamler J., Orencia A.J., Dyer A.R., Liu K., Greenland P., Walsh M.K., Morris D., Shekelle R.B. (1997). Fish consumption and the 30-year risk of fatal myocardial infarction. N. Engl. J. Med. 336: 1046–1053.
48. Das UN (2004). Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-β to prevent human essential hypertension. Eur J Clin Nutr 58: 195–203.
49. DeDeckere E.A.M. (1999). Possible beneficial effect of fish and fish n-3 polyunsaturated fatty acids in breast and colorectal cancer. Eur J Cancer Prev 8: 213–221.
50. Denburg J.A., Hatfield H.M., Cyr M.M., Hayes L., Holt P.G., Sehmi R., Dunstan J.A., Prescott S.L. (2005). Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatr Res 57: 276–281.
51. De Kock J., De Greyt W., Ayala J.V., Vanheerswynghels P., Kellens M. (2004). Removal of dioxins and PCBs from marine oils: Current status and future developments. Proc. 11th ISNFF, Phuket, Thailand: 53.
52. Dijck-Brouwer D.A.J., Hadders-Algra M., Bouwstra H., Decsi T., Boehm, Martini I.A., Boersma E.R., Muskiet F.A.J. (2005). Lower fetal status of docosahexaenoic acid, arachidonic acid and esential fatty acids is associated with less favorable neonatal neurological condition. Prostaglandins Leukotrienes Essential Fatty Acids 72:21–28.
53. Dietz R, Riget F, Johansen P (1996). Lead, cadmium, mercury and selenium in Greenland marine animals. Sci Tot Environ 186: 67–93.
54. Dolecek T.A. and Granditis G. (1991). Dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial (MRFIT). World Rev. Nutr. Diet. 66: 205–216.
55. Dunstan J.A., Roper J., Mitoulas L., Hartmann P.E., Simmer K., Prescott S.L. (2004). The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD 14, cytokine levels and fatty acid composition. Clin Exp Allergy 34: 1237–1242.
56. Dyerberg J., Bang H.O., Stoffersen E., Moncada S., Vane J.R. (1978). Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?. Lancet II: 117–119.
57. Easton MDL, Luszniak D, Von der Geest E (2002). Preliminary examination of contaminant loadings in farmed salmon, wild salmon and commercial salmon feed. Chemosphere 46: 1053–1074.
58. EC (European Commission) (2005). Scientific Committee on Health and Environmental Risks (SCHER) Opinion on “other”. europa.eu.int/comm/health/ph_risk/committees/04_scher/docs/scher_o_012.pdf.
59. EC (European Commission) (2004). Report on Tasks for Scientific Cooperation (SCOOP), task 3.2.11. Assessment of the diatary exposure to arsenic, cadmium, lead and mercury of the population of the EU Member States. European Commission, Directorate-General Health and Consumer Protection, Reports on tasks for scientific co-operation, March 2004.
60. EC (European Commission) (2003). Scientific Committee on Food (SCF). Report of the Scientific Committee on Food on the revision of the essential requirements of infant formulae and follow-on formulae. europa.eu.int/comm/food/fs/sc/scf/index_en.html.
61. EC (European Community) (2002). Directive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 on undesirable substances in animal feed. OJ L140, 30.5.2002, p10.
62. EC (European Commission) (2002). Opinion of the Scientific Committee on Toxicity, Ecotoxicity and the Environment (CSTEE). Results of the risk assessment of diphenylether, octabromo derivative [CAS No.: 32536-52-0] [EINECS No.: 251-087-9]. Environmental and human health part. Available at europa.eu.int/comm/health/ph_risk/committees/sct/documents/out166_en.pdf.
63. (2001). Commission regulation no 466/2001 setting maximum levels for certain contaminants in foodstuffs. OJ L77, 16.3.2001, p 1.
64. EC (European Commission) (2001). Opinion of the Scientific Committee on Food on the risk assessment of dioxins and dioxins-like PCBs in food (update based on the new scientific information available since the adoption of the SCF opinion of 22 November 2000). Available at: europa.eu.int/comm/food/fs/sc/scf/outcome_en.html.
65. EC (European Commission) (2000). Opinion of the Scientific Committee on animal nutrition SCAN on the dioxin contamination of feedingstuffs and their contribution to the contamination of food of animal origin. Available at (europa.eu.int/comm/food/fs/sc/scan/outcome.en.html).
66. EC (European Commission) 2000. Opinion of the Scientific Committee on Toxicity, Ecotoxicity and the Environment (CSTEE). Results of the Environmental Risk Assessment of: Decabromodiphenyl ether [CAS N° 1163-19-5] [EINECS N° 214-604-9]. Available at europa.eu.int/comm/health/ph_risk/committees/sct/docshtml/sct_out67_en.htm.
67. EC (European Commission) (2000). Opinion of the Scientific Committee on Toxicity, Ecotoxicity and the Environment (CSTEE). Opinion on the results of the Human Risk Assessment of: Pentabromodiphenyl ether [CAS N° 32534-81-9] carried out in the framework of Council Regulation (EEC) 793/93 on the evaluation and control of the risks of existing substances - Opinion expressed at the 16th CSTEE plenary meeting, Brussels, 19th of June 2000. Available at europa.eu.int/comm/health/ph_risk/committees/sct/docshtml/sct_out64_en.htm.
68. EC JRC (2004). European Union Risk Assessment Report on decabromodiphenyl ether (bis(pentabromophenyl) ether; CAS No. 1163-19-5) - Final Environmental Draft 2004: available at ecb.jrc.it/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/ADDENDUM/decabromodiphenylether_add_013.pdf.
69. EC JRC (2003). European Union Risk Assessment Report on octabromodiphenyl ether (diphenyl ether, octabromo derive. CAS No. 32536-52-0) available at ecb.jrc.it/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/octareport014.pdf.
70. EC JRC (2002). European Risk Assessment report: hexabromocyclododecane. Draft report, August 2003.
71. EC JRC (2002). European Union Risk Assessment Report on decabromodiphenyl ether (bis(pentabromophenyl) ether; CAS No. 1163-19-5) available at ecb.jrc.it/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/decabromodiphenyletherreport013.pdf.
72. EC JRC (2001). European Union Risk Assessment Report on pentabromodiphenyl ether (diphenyl ether, pentabromo deriv.; CAS No. 32534-81-9) available at ecb.jrc.it/DOCUMENTS/Existing-Chemicals/RISK_ASSESSMENT/REPORT/penta_bdpereport015.pdf.
73. EFSA (European Food Safety Authority) (2005a). Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to arsenic as undesirable substance in animal feed. (Question N° EFSA-Q-2003-031) www.efsa.eu.int/science/contam/contam_opinions/825/opinion_arsenic1.pdf.
74. EFSA (European Food Safety Authority) (2005b). Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to camphechlor as undesirable substance in animal feed. (Question N° EFSA-Q-2003-068) www.efsa.eu.int/science/contam/contam_opinions/803/finalversion2camphechlor1.pdf.
75. EFSA (European Food Safety Authority) (2005c). Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to hexachlorcyclohexane as undesirable substance in animal feed. (Question N° EFSA-Q-2003-067).
76. EFSA (European Food Safety Authority) (2005, in preparation). Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to the presence of non-dioxin-like polychlorinated biphenyls (PCBs) in food and feed. (Question N° EFSA-Q-2003-114).
77. EFSA (European Food Safety Authority) (2004a). Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to mercury and methylmercury in food (EFSA-Q-2003-030). www.efsa.eu.int/science/contam/contam_opinions/259/opinion_contam_01_en1.pdf.
78. EFSA (European Food Safety Authority) (2004b). Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission to assess the health risks to consumers associated with exposure to organotins in foodstuffs. (EFSA-Q-2003-110). www.efsa.eu.int/science/contam/contam_opinions/658_en.html.
79. EFSA (European Food Safety Authority) (2004c). Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to lead as undesirable substance in animal feed. (Request N° EFSA-Q-2003-032) www.efsa.eu.int/science/contam/contam_opinions/474/opinion03_contam_ej71_lead_en1.pdf.
80. EFSA (European Food Safety Authority) (2004d). Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to cadmium as undesirable substance in animal feed. (Question N° EFSA-Q-2003-033) www.efsa.eu.int/science/contam/contam_opinions/475/op04_contam_ej72_cadmium_en1.pdf.
81. EFSA (European Food Safety Authority) (2004e). EFSA Scientific Colloquium Summary Report 1. Methodologies and principles for setting tolerable intake levels for dioxins, furans and dioxin-like PCBs. www.efsa.eu.int/science/colloquium_series/no1_dioxins/599_en.html.
82. Endres S., Ghorbani R., Kelley V.E., Georgilis K., Lonneman G., van der Meer J.W.M., Cannon J.G., Rogers T.S., Klempner M.S., Weber P.C., Schaefer E.J., Wolfe S.M., Dinarello C.A. (1989). The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320: 265–271.
83. Eritsland J., Arnesen H., Gronseth K., Fjeld N.B., Abdelnoor M. (1996). Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am. J. Cardiol. 77: 31–36.
84. Erkkilae A.T., Lichtenstein A.H., Mozaffarian D., Herrington D.M. (2004). Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am. J. Clin. Nutr. 80: 626–632.
85. FAO (Food and Agriculture Organization) (2003a). FAO Fisheries Department, Fishery Information, Data and Statistics Unit. Fishstat Plus: Universal software for fishery statistical time series, 1950–2003. Vers. 2.30 (www.fao.org/fi/statist/fisoft/FISHPLUS.asp).
86. FAO (Food and Agriculture Organization) (2003b). The World Tuna Industry – An analysis of imports and prices, and of their combined impact on catches and tuna fishing capacity – Camillo Catarci, FAO.
87. FAO (Food and Agriculture Organisation the United Nations and World Health Organization) (WHO) (1994). Fats and oils in human nutrition. Report of a Joint Expert Consultation. Rome.
88. FAO/WHO (1991). Protein quality evaluation. Report of Joint FAO/WHO Expert Consultation. FAO Food and Nutrition Paper No. 51.
89. Feeley M. (2005). Health Canada. Personal communication.
90. Finnegan Y.E., Minihane A.M., Leigh-Firbank E.C., Kew S., Meijer G.W., Muggli R., Calder P.C., Williams C.M. (2003). Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am. J. Clin. Nutr. 77: 783–795.
91. FSAI (Food Safety Authority of Ireland) (2002). Summary of the investigations of dioxins, furans and PCBs in farmed salmon, wild salmon, farmed trout and fish oil capsules. www.fsai.ie/industry/Dioxins3.html.
92. Fox T.E., Van den Heuvel E.G.H.M., Atherton C.A., Dainty J.R., Lewis D.J., Langford N.J., Crews H.M., Luten J.B., Lorentzen M., Sieling F.W., Van Aken-Schneyder P., Hoek M., Kotterman M.J.J., Van Dael P., Fairweather-Tait S.J. (2004). Bioavailability of selenium from fish, yeast and selenate: a comparative study in humans using stable isotopes. Eur J Clin Nutr 58: 343–349.
93. FSA (UK Food Standards Agency) (2004a). Advice on fish consumption: benefits & risks. Scientific Advisory Committee on Nutrition and Committee on toxicity. Published at: www.food.gov.uk/multimedia/pdfs/fishreport2004full.pdf.
94. FSA (UK Food Standards Agency) (2004b). COT statement on brominated flame retardants in fish from the Skerne-Tees rivers system. Statement agreed December 2003. Published at: www.food.gov.uk/science/ouradvisors/toxicity/statements/cotstatements2004branch/cotstatementbfrfish2004.
95. FSA (UK Food Standards Agency) (2004c). COT statement on tetrabromobisphenol A - Review of toxicological data. Available at www.food.gov.uk/science/ouradvisors/toxicity/statements/cotstatements2004branch/cotstatements2004tbbpa.
96. FSA (UK Food Standards Agency) (2002). McCance and Widdowson's The Composition of Foods, Sixth summary edition. Cambridge, Royal Society of Chemistry.
97. Gallani B., Boix A., Verstraete F., Von Hoist C., Anklam E. (2004). Dioxins and PCBs in Food and Feed: data availble to the European Commission, 2004, EUR 21093 EN.
98. Gapinski J.P., VanRuiswyk J.V., Heudebert G.R., Schectman G.S. (1993). Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. Arch. Intern. Med. 153: 1595–1601.
99. Geleijnse J.M., Giltay E.J., Grobbee D.E., Donders A.R., Kok F.J. (2002). Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens. 20: 1493–1499.
100. Gillum R.F., Mussolino M., Madans J.H. (2000). The relation between fish consumption, death from all causes, and incidence of coronary heart disease: the NHANES I Epidemiologic Follow-up Study. J. Clin. Epidemiol. 53: 237–244.
101. Gillum R.F., Mussolino M.E., Madans J.H. (1996). The relationship between fish consumption and stroke incidence. The NHANES I Epidemiologic Follow-up Study (National Health and Nutrition Examination Survey). Arch. Intern. Med. 156: 537–542.
102. GISSI-Prevenzione Investigators (1999). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet 354: 447–455.
103. Goering P.L., Fisher B.R., Kish C.L. (1993). Stress protein synthesis induced in rat liver by cadmium precedes hepatotoxicity. Toxicol Appl Pharmacol. 122:139–48.
104. Guallar E, Sanz-Gallardo MI, Van't Veer P, Bode P, Aro A, Gomez-Aracena J, Kark JD, Riemersma RA, Martin-Moreno JM, Kok FJ. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 2002; 347: 1747–54.
105. Grandjean P, Bjerve KS, Weihe P, Steuerwald U (2001). Birthweight in a fishing community: significance of essential fatty acids and marine food contaminants. Int J Epidemiol 30: 1272–1278.
106. Grandjean P, Weihe P (2003). Arachidonic acid status during pregnancy is associated with polychlorinated biphenyl exposure. Am J Clin Nutr 77: 715–719.
107. Grigorakis K., Alexis M.N., Taylor K.D.A., Hole M. (2002). Comparison of wild and cultured gilthead sea bream (Sparus aurata); composition, appearynce and seasonal variations. Int J Food Sci Technol 37: 477–484.
108. Grundt H., Nilsen D.W.T., Hetland O., Mansoor M.A. (2004). Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction. Clin. Nutr. 23: 491–500.
109. Groot C., Margolis L., Clarke W.C. (1995). Physiological Ecology of Pacific Salmon. UBC Press, Vancouver, B.C. Canada, 510 pp.
110. Guallar E., Sanz-Gallardo M.I., Van't Veer P., Bode P., Aro A., Gomez-Aracena J., Kark J.D., Riemersma R.A., Martin-Moreno J.M., Kok F.J. (2002). Mercury, fish oils, and the risk of myocardial infarction. N. Engl. J. Med. 347: 1747–1754.
111. Gustafsson P.A., Duchén K., Birberg U., Karlsson T. (2004). Breastfeeding, very long polyunsaturated fatty acids (PUFA) and IQ at 6½ years of age. Acta Paediatr 93: 1280–1287.
112. Haglund PS, Zook DR, Buser H-R, Hu J (1997). Identification and quantification of polybrominated diphenyl ethers and methoxy-polybrominated diphenyl ethers in Baltic biota. Environmental Science and Technology 31: 3281–3287.
113. Hagmar L., Persson-Moschos M., Akesson B., Shutz A. (1998). Plasma levels of selenium, selenoprotein P and glutathione peroxidase and their correlations to fish intake and serum levels of thyrotropin and thyroid hormones: a study on Latvian fish consumers. Eur J Clin Nutr 52: 796–800.
114. Hardy R.W., Scott T.M., Harrell L.W. (1987). Replacement of herring oil with menhaden oil, soybean oil, or tallow in the diets of Atlantic salmon raised in marine net-pens. Aquaculture 62: 267–277.
115. Harris W.S., Connor W.E., Lindsey S. (1984). Will dietary omega-3 fatty acids change the composition of human milk? Am J Clin Nutr 40: 780–785.
116. Harris W.S. (1997). n-3 Fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65: 1645S–1654S.
117. Halver J.E. and Hardy R.W. (2002). Fish Nutrition, 3rd Edition. Academic Press, Inc., New York. 824 pp.
118. He K., Rimm E.B., Merchant A., Rosner B.A., Stampfer M.J., Willett W.C., Ascherio A. (2002). Fish consumption and risk of stroke in men. J. Am. Med. Assoc. 288: 3130–3136.
119. He K., Song Y., Daviglus M.L., Liu K., Van Horn L., Dyer A.R., Greenland P. (2004b). Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109: 2705–2711.
120. He K., Song Y., Daviglus M.L., Liu K., Van Horn L., Dyer A.R., Greenland P. (2004a). Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke 35: 1538–1542.
121. Helland I.B., Smith L., Saarem K., Saugstad O.D., Drevon C.A. (2003). Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 111:39–44.
122. Helland I.B., Saugstad O.D., Smith L., Saarem K., Solvoll K., Ganes T., Drevon C.A. (2001). Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 108: 82–91.
123. Henninger M. and Ulberth F. (1997). Fettsäurespektren von heimischen Fischen, Seefischen und Fischölen. Dtsch. Lebensmittel-Rundschau 93: 178–183.
124. Hjartåker A. (2003). Fish consumption and risk of breast, colorectal and prostate cancer: a critical evaluation of epidemiological studies. Scand J Nutr 47: 111–122.
125. Hites R.A., Foran J.A., Carpenter D.O., Hamilton M.C., Knuth B.A., Schwager S.J. (2004a). Global Assessment of Organic Contaminants in Farmed Salmon Science, 303: 226–229 www.nal.usda.gov/fnic/foodcomp/search/.
126. Hites, R A, Foran A, Schwager S J, Knuth B A, Hamilton MC, Carpenter DO (2004b). Global assessment of polybrominated diphenyl ethers in farmed and wild salmon. Environmental Science and Technology 38: 4945–4949.
127. Hooper L., Thompson R.L., Harrison R.A., Summerbell C.D., Moore H., Worthington H.V., Durrington P.N., Ness A.R., Capps N.E., Davey Smith G., Riemersma R.A., Ebrahim S.B.J. (2004). Omega 3 fatty acids for prevention and treatment of cardiovascular disease. The Cochrane Database of Systematic Reviews, Issue 4. Art. No: CD003177. pub2. DOI: 10.1002/14651858.CD003177.pub2.
128. Hornstra G. (2001). Influence of dietary fat type on arterial thrombosis tendency. J. Nutr. Health Aging 5: 160–166.
129. Howe P.C. (1995). Can we recommend fish oil for hypertension? Clin Exper Pharmacol Physiol 22: 199–203.
130. Hu F.B., Bronner L., Willett W.C., Stampfer M.J., Rexrode K.M., Albert C.M., Hunter D., Manson J.E. (2002). Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. J. Am. Med. Assoc. 187: 1815–1821.
131. Huang W., Akesson B., Svensson B.G., Schütz A., Burk R.F., Skerfving S. (1995). Serum selenoprotein P and glutathione peroxidase (EC 1.11.1.9) in plasma as indices of selenium status in relation to intake of fish. Br J Nutr 73: 455–461.
132. IARC (International Agency on Research in Cancer) (2004). Inorganic and organic lead, Vol 87 193.51.164.11/htdocs/announcements/vol87.htm.
133. IARC (International Agency for Cancer Research) (2002). Some Drinking water disinfectants and contaminants including arsenic. IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 84, 15–22 October 2002.
134. IARC (International Agency for Research on Cancer) (1987). Hexachlorocyclohexanes (Group 2B). In: Overall evaluations of carcinogenicity. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Supplement 7. Lyon, France.
135. IARC (International Agency for Research on Cancer) (1979). Hexachlorocyclohexane (technical HCH and lindane). In: Some Halogenated Hydrocarbons. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Vol. 20. Lyon, France.
136. Institute of Medicine (IOM) Food and Nutrition Board (2002). Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. www.iom.edu/report.asp?id=4340.
137. International Society for the Study of Fatty Acids and Lipids (ISSFAL) (2004). Recommendations for intake of polyunsaturated fatty acids in adults. www.issfal.org.uk/pufa%20intakes.htm.
138. Iso H., Rexrode K.M., Stampfer M.J., Manson J.E., Colditz G.A., Speizer F.E., Hennekens C.H., Willett W.C. (2001). Intake of fish and omega-3 fatty acids and risk of stroke in women. J. Am. Med. Assoc. 285: 304–312.
139. Isosaari, P., Lundebye, A.-K., Ritchie, G., Lie, Ø., Kiviranta, H. & Vartiainen, T. (2005). Dietary accumulation efficiencies and biotransformation of poly-brominated diphenyl ethers in farmed Atlantic salmon (Salmo salar). Food Additives and Contaminants, accepted.
140. Isosaari P., Kiviranta H., Lie O., Lundebye A.-K., Ritchie G., Vartiainen T. (2004). Accumulation and distribution of polychlorinated dibenzo-p-dioxin, dibenzofuran, and polychlorinated biphenyl congeners in Atlantic salmon (Salmo Salar). Environ. Toxicol. Chem. 23 (7): 1672–1679.
141. Isosaari P., Vartiainen T., Hallikainen A., Ruohonen K. (2002). Feeding trial on rainbow trout: comparison of dry fish feed and Baltic herring as a source of PCDD/Fs and PCBs. Chemosphere 48 (8): 795–804.
142. Jacobs MN, Covaci A, Schepens P (2002). Investigation of selected persistent organic pollutants in farmed Atlantic salmon (Salmo salar), salmon aquaculture feed, and fish oil components of the feed. Environmental Science and Technology 36: 2797–2805.
143. James M.J., Gibson R.A., Cleland L.G. (2000). Dietary polyunsturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71 (Suppl): 343S–348S.
144. Johansen O., Brekke M., Seljeflot I., Abdelnoor M., Arnesen H. (1999). n-3 Fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. J. Am. Coll. Cardiol. 33: 1619–1626.
145. Joiris C.R., Holsbeek L., Moatermi N.L. (1999). Total and methylmercury in sardines Sardinella aurita and Sardina pilchardus from Tunisia. Marine Pollution Bulletin, 38: 188–192.
146. Ju J.T. and Nordberg M. (1998). Toxicokinetics and biochemistry of cadmium with special emphasis on role of metallothionein. Neurotoxicology. 19: 529–535.
147. Julshamn K, Ringdal O, Brækkan OR (1982). Mercury concentrations in liver and muscle of cod (Gadus morhua) as an evidence of migration between waters with different levels of mercury. Bull. Environ. Contam. Toxicol. 29: 544.
148. Kamps L.R. and Miller H. (1972). Total mercury-monomethylmercury content of several species of fish. Bulletin of Environmental Contamination and Toxicology, 8, 273.
149. Kang J.X. and Leaf A. (2000): Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids. Am. J. Clin. Nutr. 71: 202S–207S.
150. Karl H., Ruoff U., Blüthgen A. (2003). Transfer of PCDDs and PCDFs into the edible parts of farmed rainbow trout, Oncorhynchus mykiss (Walbaum), via feed. Aquaculture Research 34: 1009–1014.
151. Karl H., Kuhlmann H., Oetjen K. (2002). Transfer of toxaphene and chlordane into farmed rainbow trout, Oncorhynchus mykiss (Walbaum) via feed. Aquaculture Research 33: 925–932.
152. Keli S.O., Feskens E.J., Kromhout D. (1994). Fish consumption and risk of stroke. The Zutphen Study. Stroke 25: 328–332.
153. Kelley D.S., Taylor P.C., Nelson G.J., Schmidt P.C., Ferretti A., Erickson K.L., Yu R., Chandra R.K., Mackey B.E. (1999). Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 34: 317–324.
154. Kierkegaard A, Balk L, Tjärnlund U, De Wit C, Jansson B (1999). Dietary uptake and biological effects of decabromodiphenyl ether in rainbow trout (Oncorhynchus mykiss). Environmental Science and Technology 33:1612–1617.
155. Kohlmeyer U., Kuballa J., Jantzen E. (2002). Simultaneous Separation of 17 inorganic and organic arsenic compounds in marine biota by means of high performance liquid chromatography/inductively coupled plasma mass spectrometry. Rapid Communications in Mass Spectrometry. 16: 965–974.
156. Koletzko B., Thiel I., Abiodun P.O. (1992). The fatty acid composition of human milk in Europe and Africa. J Pediatr 120: S62–S70.
157. Kraal, MH, Kraak MH, Degroot CJ, Davids C (1995). Uptake and tissue distribution of dietary and aqueous cadmium by carp (Cyprinus carpio). Ecotox. Environ. Safety 31: 179–83.
158. Kremer J.M., Lawrence D.A., Jubiz W., DiGiacomo R., Rynes R., Bartholomew L.E., Sherman M. (1990). Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 33: 810–820.
159. Kris-Etherton P.M., Harris W.S., Appel L.J. (2003). Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106: 2747–2757.
160. Kromhout D., Bloemberg B.P., Feskens E.J., Hertog M.G., Menotti A., Blackburn H. (1996). Alcohol, fish, fibre and antioxidant vitamins intake do not explain population differences in coronary heart disease mortality. Int. J. Epidemiol. 25: 753–759.
161. Kromhout D., Menotti A., Bloemberg B., Aravanis C., Blackburn H., Buzina R., Dontas A.S., Fidanza F., Giampaoli S., Jansen A. et al. (1995). Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev. Med. 24: 308–315.
162. Kromhout D., Bosschieter E.B., Coulander C. (1985). The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N. Engl. J. Med. 312: 1205–1209.
163. Lanphear B.P., Dietrich K., Auinger P., Cox C. (2000). Cognitive deficits associated with blood lead concentrations < 10 mirog/dL in US children and adolescents. Public Health Rep. 115, 521–529.
164. Lee T.H., Hoover R.L., Williams J.D., Sperling R.I., Ravalese J. 3rd, Spur B.W., Robinson D.R., Corey E.J., Lewis R.A., Austen K.F. (1985). Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 312: 1217–1224.
165. Li Z., Lamon-Fava S., Otvos J., Lichtenstein A.H., Velez-Carrasco W., McNamara J.R., Ordovas J.M., Schaefer E.J. (2004). Fish consumption shifts lipoprotein subfractions to a less atherogenic pattern in humans. J Nutr 134: 1724–1728.
166. Lidsky T.I. and Schneider J.S. (2003). Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain 126, 5–19.
167. Liebert F. and Portz L. (2005). Aquaculture (in press).
168. Lim C. and Klesius P.H. (2004). Use of Alternative Protein Sources in Diets of Warmwater Fish. Proc. 11th ISNFF, Phuket, Thailand: 30.
169. Lock, RAC (1975). Uptake of methylmercury by aquatic organisms from water and food. In: Sublethal effects of toxic chemicals on aquatic animals, J.H. Koeman and J.J.T.W.A. Strik, Elsevier, Amsterdam, pp. 61–79.
170. Love R.M. (1988). The Food Fishes: their Intrinsic Variation and Practical Value. Farrand Press, London. 276 pp.
171. Love R.M. (1980). The Chemical Biology of Fishes. Volume 2. Academic Press, London. 943 pp.
172. Lundebye A.-K., Bernttsen M.H.G., Lie O., Ritchie G., Isosaari P., Kiviranta H., Vartiainen T. (2004). Dietary uptake of dioxins (PCDD/PCDFs) and dioxin-like PCBs in Atlantic salmon (Salmo Salar). Aquaculture Nutrition 10: 199–207.
173. Maage A, Julshamn K, Berntssen MHG, Lundebye Haldorsen A-K, Lorentzen M (2005). Surveillance of contaminants in Norwegian salmon fillets and salmon feeds, some highlights from 1995–2003. Fish Farming Today 196.
174. Ministry of Agriculture, Fisheries and Food (MAFF) (1998). Fatty acids. Supplement to McCance & Widdowson's The Composition of Foods. Cambridge Royal Society of Chemistry and London Ministry of Agriculture, Fisheries and Food.
175. Mambrini M., Roem A.J., Cravèdi J.P., Lallès J.P., Kaushik S.J. (1999). Effects of Replacing Fish Meal with Soy Protein Concentrate and of DL-Methionine Supplementation in High-Energy, Extruded Diets on the Growth and Nutrient Utilization of Rainbow Trout, Oncorhynchus mykiss. J. Anim. Sci. 77: 2990–2999.
176. Manchester-Neesvig JB, Valters K, Sonzogni WS (2001). Comparison of polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) in Lake Michigan salmonids. Environmental Science and Technology 35: 1072–1077.
177. Marchioli R., Barzi F., Bomba E., Chieffo C., Di Gregorio D., Di Mascio R., Franzosi M.G., Geraci E., Levantesi G., Maggioni A.P., Mantini L., Marfisi R.M., Mastrogiuseppe G., Mininni N., Nicolosi G.L., Santini M., Schweiger C., Tavazzi L., Tognoni G., Tucci C., Valagussa F. (2002). Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105: 1897–1903.
178. Marckmann P. and Gronbaek M. (1999). Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur. J. Clin. Nutr. 53: 585–590.
179. Martin A. (2001). Apports nutritionnnels conseillés pour la population française. Tec & Doc, 3e édition, Paris.
180. Martinez M. (1992). Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 120: S129–S138.
181. McKenzie (2001). Effects of dietary fatty acids on the respiratory and cardiovascular physiology of fish. Comp Biochem Physiol A Mol Integr Physiol 128: 607–621.
182. Meltzer H.M., Bibow K., Paulsen I.T., Mundal H.H., Norheim G., Holm H. (1993). Different bioavailability in humans of wheat and fish selenium as measured by blood platelet response to increased dietary Se. Biol Trace Elem Res 36: 229–241.
183. McLennan P.L. (2001). Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 36: S111–S114.
184. Meydani S.N., Lichtenstein A.H., Cornwall S., Meydani M., Goldin B.R., Rasmussen H., Dinarello C.A., Schaefer E.J. (1993). Immunologic effects of a National Cholesterol Education Panel step 2-diet with and without fish-derived n-3 fatty acid enrichment. J Clin Invest 92: 105–113.
185. Morris M.C., Manson J.E., Rosner B., Buring J.E., Willett W.C., Hennekens C.H. (1995). Fish consumption and cardiovascular disease in the physicians' health study: a prospective study. Am. J. Epidemiol. 142: 166–175.
186. Morris M.C., Sacks F., Rosner B. (1993). Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88: 523–533.
187. Mozaffarian D., Lemaitre R.N., Kuller L.H., Burke G.L., Tracy R.P., Siscovick D.S. (2003). Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 107: 1372–1377.
188. Nelson G.J., Schmidt P.C., Bartolini G.L., Kelley D.S., Kyle D. (1997a). The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acidcomposition in humans. Lipids 32: 1137–1146.
189. Nelson G.J., Schmidt P.C., Bartolini G.L., Kelley D.S., Kyle D. (1997b). The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 32: 1129–1136.
190. Nilsen D.W.T., Albrektsen G., Landmark K., Moen S., Aarsland T., Woie L. (2001). Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am. J. Clin. Nutr. 74: 50–56.
191. Nettleton J. A. (2000). Fatty acids in cultivated and wild fish. oregonstate.edu/dept/IIFET/2000/papers/nettleton2.pdf.
192. Nichols P., Mooney B., Elliott N. (2003). Is farmed Australian seafood a better source of the good oil than wild-caught seafood? Asia Pac J Clin Nutr 12 Suppl: S34.
193. NRC (National Research Council) (2000). Toxicological effects of Methylmercury. National Academy Press, Washington, DC.
194. Ohta S, Ishizuka D, Nishimura H, Nakao T, Aozasa O, Shimidzu Y, Ochiai F, Kida T, Nishi M, Miyata H (2002). Comparison of polybrominated diphenyl ethers in fish, vegetables, and meats and levels in human milk of nursing women in Japan. Chemosphere 46: 689–696.
195. Oken E, Wright RO, Kleinman KP, Bellinger D, Amarasiriwardena CJ, Hu H, Rich-Edwards JW, Gillman MW (2005). Maternal fish consumption, hair mercury, and infant cognition in a US cohort. Environm Health Perspect doi: 10.1289/ehp.8041.
196. Olsen S.F. and Secher H.J. (2002). Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study. Brit Med J 324: 447–450.
197. Olsen S.F., Hansen H., Secher N.J., Sandstroem B. (1995). Gestation length and birth weight in relation to intake of marine n-3 fatty acids. Brit J Nutr 73: 397–404.
198. Olsen S.F., Hansen H.S., Sommer S., Jensen B., Sorensen T.I., Secher N.J., Zachariassen P. (1991). Gestational age in relation to marine n-3 fatty acids in maternal erythrocytes: a study of women in the Faroe Islands and Denmark. Am J Obste Gynecol 164: 1203–1209.
199. Onwude J.L., Lilford R.J., Hjartardottir H., Staines A., Tuffnell D. (1995). A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol 102: 95–100.
200. Orencia A.J., Daviglus M.L., Dyer A.R., Shekelle R.B., Stamler J. (1996). Fish consumption and stroke in men. 30-year findings of the Chicago Western Electric Study. Stroke 27: 204–209.
201. Osler M., Andreasen A.H., Hoidrup S. (2003). No inverse association between fish consumption and risk of death from all-causes, and incidence of coronary heart disease in middle-aged, Danish adults. J. Clin. Epidemiol. 56: 274–279.
202. Ostermeyer U. and Schmidt T. (2004). Differentiation of wild salmon, conventionally and organically farmed salmon. Dtsch Lebensm Rundsch 100:437–444.
203. Pischon T., Hankinson S.E., Hotamisligil G.S., Rifai N., Willett W.C., Rimm E.B. (2003). Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 108: 155–160.
204. Popeski D., Ebbeling L.R., Brown P.B., Hornstra G., Gerrard J.M. (1991). Blood pressure during pregnancy in Canadian Inuit: community differences related to diet. Can Med Assoc J 145: 445–454.
205. Prescott S.L. and Calder P.C. (2004). N-3 polyunsaturated fatty acids and allergic disease. Curr Opin Nutr Metab Care 7: 123–129.
206. Remans P.H.J., Sont J.K., Wagenaar L.W., Wouters-Wesseling W., Zuijderduin W.M., Jongma A., Breedveld F.C., Van Laar J.M. (2004). Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects. Eur J Clin Nutr 58: 839–845.
207. Repertoire Général de Aliments, TEC et DOC ed. (1991).
208. Rissanen T., Voutilainen S., Nyyssonen K., Lakka T.A., Salonen J.T. (2000). Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. Circulation 102: 2677–2679.
209. Rodriguez A., Sarda P., Nessmann C., Boulot P., Poisson J.P., Leger C.L., Descomps B. (1998): Fatty acid desaturase activities and polyunsaturated fatty acid composition in human fetal liver between the seventeenth and thirty-sixth gestational weeks. Am. J. Obstet. Gynecol. 179: 1063–1070.
210. Rodriguez B.L., Sharp D.S., Abbott R.D., Burchfiel C.M., Masaki K., Chyou P.H., Huang B., Yano K., Curb J.D. (1996). Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers. The Honolulu Heart Program. Circulation 94: 952–956.
211. Rueda F.M., Lopez J.A., Martinez F.J., Zamora S. (1997). Fatty acids in muscle of wild and farmed red porgy, Pagrus pagrus. Aquaculture Nutr 3: 161–165.
212. Rueda F.M., Hernandez M.D., Egea M.A., Aguado F., Garcia B., Martinez F.J. (2001). Differences in tissue fatty acid composition between reared and wild sharpsnout sea bream, Diplodus puntazzo (Cetti, 1777) Br J Nutr 86: 617–622.
213. Ruprich J (1997): Study of freshwater fish consumption: anglers in the Czech Republic (in Czech), Report IGA MZ CR No. 2762–3, www.chpr.szu.cz/nutrice/ryby.html31.12.2004.
214. Sacks F.M. and Katan M. (2002). Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am. J. Med. 113: 13S–24S.
215. Sacks F.M., Stone P.H., Gibson C.M., Silverman D.I., Rosner B., Pasternak R.C. (1995). Controlled trial of fish oil for regression of human coronary atherosclerosis. J. Am. Coll. Cardiol. 25: 1492–1498.
216. Sargent J.R. and Tacon A.G.J. (1999). Development of farmed fish: a nutritionally necessary alternative to meat. Proc Nutr Soc 58: 377–383.
217. Schecter A., Papke O, Tung KC, Staskal D, Birnbaum L (2004). Polybrominated diphenyl ether contamination of United States food. Environ. Sci. Technol. 38(20): 5306–5311.
218. Schubert A., Holden J.M., Wolf W.R. (1987). Selenium content of a core group of foods based on a critical evaluation of published analytical data. J Am Dietet Assoc 87: 285–299.
219. Seierstad S.L., Seljeflot I., Johansen O., Hansen R., Haugen M., Rosenlund G., Froyland L., Arnesen H. (2005). Dietary intake of differently fed salmon; the influence on markers of human atherosclerosis. Eur J Clin Investig 35: 52–59.
220. Selevan S.G., Rice D.C., Hogan K.A., Euling S.Y., Phahles-Hutchens A. and Bethel J. (2003). Blood lead concentration and delayed puberty in girls. N. Engl. J. Med. 348, 1527–1536.
221. Shearer K.D. (1994). Factors affecting the proximate composition of cultured fishes with emphasis on salmonids. Aquaculture 119: 63–88.
222. Sidhu K.S. (2003). Health benefits and potential risks related to consumption of fish or fish oil. Regul Toxicol Pharmacol 38: 336–344.
223. Silbergeld E.K. (2003). Facilitative mechanisms of lead as a carcinogen. Mutation Research 533: 121–133.
224. Simopoulos A.P., Leaf A., Salem N. Jr. (1999). Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann. Nutr. Metab. 43: 127–130.
225. Singh R.B., Niaz M.A., Sharma J.P., Kumar R., Rastogi V., Moshiri M. (1997). Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival - 4. Cardiovasc. Drugs Ther. 11: 485–491.
226. Smuts C.M., Huang M., Mundy D., Plasse T., Major S., Carlson S.E. (2003). A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 101: 469–479.
227. Somero G, Chow T, Yancey P, Snyder C (1977). Lead accumulation rates in tissues of the estuarine teleost fish Gillichthys mirabilis: salinity and temperatue effcts. Bull. Environ. Contam. Toxicol. 6: 337.
228. Soriguer F., Serna S., Valverde E., Hernando J., Martin-Reyes A., Soriguer M., Pareja A., Tinahones F., Esteva I. (1997). Lipid, protein and calorie content of different Atlantic and Mediterranean fish, shellfish, and molluscs commonly eaten in the south of Spain. Eur J Epidemiol 13: 451–463.
229. Souci, Fachmann, Kraut (2000). Food Composition and Nutrition Tables. 6th Edition. Deutsche Forschungsanstalt für Lebensmittelchemie (Ed) Medpharm, Stuttgart.
230. Stapleton HM, Alaee M, Letcher RJ, Baker JE (2004a). Debromination of the flame retardant decabromodiphenyl ether in juvenile carp (Cyprinus carpio) following dietary exposure. Environmental Science and Technology 38: 112–119.
231. Stapleton HM, Letcher RJ, Li J, Baker RA (2004b). Dietary accumulation and metabolism of polybrominated diphenyl ethers by juvenile carp (Cyprinus carpio). Environmental Toxicology and Chemistry 23: 1939–1946.
232. Stapleton HM, Letcher RJ, Baker RA (2004c). Debromination of polybrominated diphenyl ether congeners BDE 99 and BDE 183 in the intestinal tract of the common carp (Cyprinus carpio). Environmental Science and Technology 38: 1054–1061.
233. Stapleton HM, Letcher RJ, Baker JE (2002). Uptake, metabolism and depuration of polybrominated diphenyl ethers (PBDEs) by the common carp, (Cyprinus carpio). Organohalogen Compounds 58: 201–204.
234. Stapleton HM, Alaee M, Letcher RJ, Baker JE (2004a). Debromination of the flame retardant decabromodiphenyl ether in juvenile carp (Cyprinus carpio) following dietary exposure. Environmental Science and Technology 38: 112–119.
235. Stapleton HM, Letcher RJ, Baker JE (2002). Uptake, metabolism and depuration of polybrominated diphenyl ethers (PBDEs) by the common carp, (Cyprinus carpio). Organohalogen Compounds 58: 201–204.
236. Stavenow L. and Kjellström T. (1999). Influence of serum triglyceride levels on the risk for myocardial infarction in 12 510 middle aged males: interaction with serum cholesterol. Atherosclerosis 147: 243–247.
237. Stone N.J. (1996). Fish consumption, fish oil, lipids, and coronary heart disease. Circulation 94: 2337–2340.
238. Steffens W. (1979). Moderne Fischwirtschaft. Verlag J. Neumann-Neudamm, Melsungen.
239. Storelli M.M., Giacominelli Stuffler R., Marcotrigiano G.O. (2001). Total mercury and methylmercury in Auxis rochei, Prionacee glauca and Squalus acanthias from the South Adriatic Sea. Italian Journal of Food Science, 13: 103–108.
240. Svensson B.G., Schütz A., Nilsson A., Akesson I., Akesson B., Skerfving S. (1992). Fish as a source of exposure to mercury and selenium. Sci Total Envuron 126: 61–74.
241. Tacon A.G.J. (2003). Global trends in aquaculture & compound aquafeed production. International Aquafeed Directory 2003: 8–23.
242. Terry P., Rohan T.E., Wolk A., Maehle-Schmidt M., Magnusson C. (2002a). Fish consumption and breast cancer risk. Nutrition Cancer 44: 1–6.
243. Terry P., Wolk A., Vainio H., Weiderpass E. (2002b). Fatty fish consumption lowers the risk of endometrial cancer: a nationwide case-control study in Sweden. Cancer Epidemiol Biomarkers Prev 11: 143–145.
244. Tomy GT, Palace VP, Halldorson T, Braekevelt E, Danell R, Wautier K, Evans B, Brinkworth L, Fisk AT (2004). Bioaccumulation, biotransformation, and biochemical effects of brominated diphenyl ethers in juvenile lake trout (Salvelinus namaycush). Environmental Science and Technology 38: 1496–1504.
245. Tryphonas H., Arnold D.L., Bryce F., Huang J., Hodgen M., Ladouceur D.T., Fernie S., Lepage-Parenteau M. and Hayward S. (2001). Effects of toxaphene on the immune system of cynomolgus (Macaca fascicularis) monkeys. Food Chem Toxicol 39(9):947–58.
246. Ulbricht T.L.V. and Southgate D.A.T. (1991). Coronary heart disease: seven dietary factors. Lancet 338: 985–992.
247. Van den Berg M., Birnbaum L., Bosveld A.T.C, Brunström B., Cook P., Feeley M., Giesy J.P., Hanberg A., Hasegawa R., Kennedy S.W., Kubiak T., Larsen J.C., Van Leeuwen F.X.R., Liem D.A.K., Nolt C., Peterson R.E., Poellinger L., Safe S., Schrenk D., Tillitt D., Tysklind M., Younes M., Waern F., Zacharewski T. (1998). ‘Toxic Equivalency Factor (TEFs) for PCBs, PCDDs, PCDFs for Humans and Wildlife’ Environ Health Perspect 106: 775–792.
248. Viberg H., Frederiksson A., Jacobsson E., Örn U., Eriksson P. (2003a). Neurobehavioral derangements in adult mice receiving decabrominated diphenyl ether (PBDE 209) during a defined period of neonatal brain development. Toxicol Sci 76:112–120.
249. Viberg H., Fredriksson A., Eriksson P. (2003b) Neonatal exposure to polybrominated diphenyl ether (PBDE 153) disrupts spontaneous behaviour, impairs learning and memory, and decreases hippocampal cholinergic receptors in adult mice. Toxicol Appl Pharmacol 192: 95–106.
250. Van Houwelingen A.C., Sorensen J.D., Hornstra G., Simonis M.M., Olsen S.F., Secher N.J. (1995). Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy. Brit J Nutr 74: 723–731.
251. Van Vliet T. and Katan M.B. (1990). Lower ratio of n-3 to n-6 fatty acids in cultured than in wild fish. Am J Clin Nutr 51:1–2.
252. Virtanen J.K., Voutilainen S., Rissanen T.H., Mursu J., Tuomainen T.P., Korhonen M.J., Valkonen V.P., Seppanen K., Laukkanen J.A., Salonen J.T. (2005). Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler. Thromb. Vasc. Biol. 25: 228–233.
253. Von Schacky C., Angerer P., Kothny W., Theisen K., Mudra H. (1999). The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 130: 554–562.
254. Wang C, Chung M, Balk E, Kupelnik B, DeVine D, Lawrence A, Lichtenstein A, Lau J (2004). Effects of omega-3 fatty acids on cardiovascular disease. AHRQ Publication No. 04-E009-2.
255. WHO (2005). Joint FAO/WHO expert Committee on Food Additives (JECFA). Summary and conclusions of the sixty-fourth meeting, Rome, 8–17 February 2005. World Health Organization, Geneva, Switzerland. www.who.int/ipcs/food/jecfa/summaries/en/summary_report_64_final.pdf.
256. WHO (2004). Joint FAO/WHO expert Committee on Food Additives (JECFA). Safety Evaluation of Certain Food Additives and Contaminants. Food Additives Series 52. World Health Organization, Geneva, Switzerland.
257. WHO (World Health Organization) (2003). Diet, nutrition and the prevention of chronic diseases. WHO Technical Report Series 916, Geneva.
258. WHO (2002). Joint FAO/WHO Expert Committee on Pesticide Residues (JMPR). Pesticide residues in food. Lindane. World Health Organization, Geneva, Switzerland. www.inchem.org/documents/jmpr/jmpmono/2002pr08.htm.
259. WHO (2001). Joint FAO/WHO expert Committee on Food Additives (JECFA). Safety Evaluation of Certain Food Additives and Contaminants. Polychlorinated dibenzodioxins, polychlorinated dibenzofurans, and coplanar polychlorinated biphenyls. Food Additives Series: 48. World Health Organization, Geneva, Switzerland. www.inchem.org/documents/jecfa/jecmono/v48je20.htm.
260. WHO (2000). Joint FAO/WHO Expert Committee on Food Additives (JECFA). Safety Evaluation of Certain Food Additives and Contaminants. Food Additives Series: 44. World Health Organization, Geneva, Switzer.
261. WHO (1999). Joint FAO/WHO Expert Committee on Food Additives (JECFA). Safety Evaluation of Certain Food Additives and Contaminants. Fifty-third report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series 896. World Health Organization, Geneva, Switzerland.
262. WHO (1993). Joint FAO/WHO Expert Committee on Food Additives (JECFA). Safety Evaluation of certain food additives and contaminants. Forty-first report of the WHO technical report series no. 837. World Health Organization, Geneva, Switzerland.
263. WHO (1988). Joint FAO/WHO expert Committee on Food Additives (JECFA). Safety Evaluation of Certain Food Additives and Contaminants. WHO Food Additives Series 24. World Health Organization, Geneva, Switzerland. www.inchem.org/documents/jecfa/jecmono/v024je08.htm.
264. WHO (1984). Camphechlor. Environmental Health Criteria 45. International Programme on Chemical Safety IPCS) World Health Organisation Geneva.
265. Williams C., Birch E.E., Emmett P.M., Northstone K., the ALSPAC Study team (2001). Stereoacuity at age 3.5 y in children born full-term is associated with prenatal and postnatal dietary factors: a report from a population-based cohort study. Am J Clin Nutr 73: 316–322.
266. Yuan J.M., Ross R.K., Gao Y.T., Yu M.C. (2001). Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am. J. Epidemiol. 154: 809–816.
267. Alaee M., Luross J., Sergeant D.B., Muir D.C.G., Whittle D.M., Solomon K. (1999). Distribution of polybrominated diphenyl ethers in the Canadian Environment. Organohalogen Compounds. 40:347–350.
268. Asplund L., Athanasiadou M., Sjodin A., Bergman, Borjesson H. (1999). Organohalogen substances in muscle, egg and blood from healthy Baltic salmon (Salmo salar) and Baltic salmon affected by the M74 syndrome. Ambio 28:67–76.
269. Asplund L., Bignert A., Nylund K. (2004). Comparison of spatial and temporal trends of methoxylated PBDEs, PBDEs and hexabromocyclododecane in herring along the Swedish coast. Organohalogen Compounds. Vol 66.
270. Burreau S., Broman D., Zebuhr Y. (1999). Biomagnification quantification of PBDEs in fish using stable nitrogen isotopes. Organohalogen Compounds. 40:363–366.
271. Centre for Environment, Fisheries and Aquaculture Science (CEFAS). Survey of brominated flame retardant residues in eel and trout from River Skerne and River Tees. (2003). Chemisches und Veterinaruntersuchungsamt Freiburg. Annual report (Jahresbericht) 2001.
272. Covaci A., Bervoets L., Hoff P., Voorspoels S., Voets J., Van Campenhout K., Blust R., Schepens P. PBDEs in freshwater mussels and fish from Flanders, Belgium. Organohalogen Compounds. Vol 66 (2004).
273. Darnerud P.O., Atuma S., Aune M., et al. Toxicol Lett. (2000). Suppl. 1/116, 28.
274. De Wit C.A., Fisk A.T., Hobbs K.E., Muir D.C.G., Gabrielsen G.W., Kallenborn R., Krahn M.M., Norstrom R.J., Skaare J.U. (2004). AMAP Assessment 2002: Persistent Organic Pollutants in the Arctic. Arctic Monitoring & Assessment Programme, Oslo, Norway, 2004.
275. Dodder N.G., Strandberg B., Hites R.A. (2002). Concentrations and spatial variations of polybrominated diphenyl ethers and several organochlorine compounds in fishes from the northeastern United States. Environ Sci Technol. Jan 15; 36(2):146–51.
276. Erdogrul O., Covaci A., Schepens P. Levels and distribution of organohalogenated contaminants in 5 fish species from Sir Dam Lake, Kahramanmaras, Turkey. Organohalogens Compounds. Vol 66 (2004).
277. Haglund P., Zook D.R., Buser H.-R., Hu J. (1997). Identification and quantification of polybrominated diphenyl ethers and methoxy-polybrominated diphenylethers in Baltic biota. Environ. Sci. Technol. 31: 3281–3287.
278. Hites R., Foran J., Schwager S., Knuth B., Hamilton C., Carpenter D. Global assessment of polybrominated diphenyl ethers in farmed and wild salmon. Organohalogen Compounds. Vol 66 (2004).
279. Jacobs M.N., Covaci A., Schepens P. Investigation of selected persistent organic pollutants in farmed Atlantic salmon (Salmo salar), salmon aquaculture feed, and fish oil components of the feed. Environ Sci Technol. (2002) Jul 1; 36(13):2797–805.
280. Karl H., Kuhlmann H., Oetjen K. (2002). Transfer of toxaphene and chlordane into farmed rainbow trout, Oncorhynchus mykiss (Walbaum) via feed. Aquaculture Research 33: 925–932.
281. Kierkegaard A., Sellstrom U., Bignert A., Olsson M., Asplund L., Jansson B., De Wit C. (1999). Temporal trends of a polybrominated diphenyl ether (PBDE), a methoxylated PBDE and hexabromocyclododecane (HBCD) in Swedish biota. Organohalogen Compd. 40, 367–370.
282. Law R.J., Alaee M., Allchin C.R., Boon J.P., Lebeuf M., Lepom P., Stern G.A. Levels and trends of polybrominated diphenylethers and other brominated flame retardants in wildlife. Environ Int. (2003). Sep; 29(6):757–70. Review.
283. Loganathan B.G., Kannan K., Watanabe I., Kawano M., Irvine K., Kumar S., Sikka H.C., (1995). Isomer-specific determination and toxic evaluation of polychlorinated biphenyls, polychlorinated/brominated dibenzo-p-dioxins and dibenzofurans, polybrominated biphenyl ethers, and extractable organic halogen in carp from Buffalo River, New York. Environ. Sci. Technol. 29: 1832–1838.
284. Luksemberg W., Wenning R., Maier M., Patterson A., Braithwaite S. Polybrominated diphenyl ethers (PBDE) and polychlorinated dibenzo-P-dioxins (PCDD/F) and biphenyls (PCB) in fish, beef and fowl purchased in food markets in Northern California, USA. Organohalogen Compounds. Vol 66 (2004).
285. Luross J.M., Alaee M., Sergeant D.B., Whittle D.M., Solomon K.R., (2000). Spatial and temporal distribution of polybrominated diphenyl ethers in lake trout from the Great Lakes. Organohalogen Compd. 47: 73–76.
286. Luross J.M., Alaee M., Sergeant D.B., Cannon C.M., Whittle D.M., Solomon K.R., Muir D.C. Spatial distribution of polybrominated diphenyl ethers and polybrominated biphenyls in lake trout from the Laurentian Great Lakes. Chemosphere. (2002) Feb; 46(5):665–72.
287. Nylund K., Kierkegaard A., Erikson U., Asplund L., Biegnert A., Olsson M. Spatial distribution of some polybrominated diphenylethers and hexabromocyclodecance in herring (Clupea harengus) along the Swedish coast. Brominated Flame Retardant Workshop (BFR). Stockholm, 349–352. (2001).
288. Ohta S., Ishizuka D., Nishimura H., Nakao T., Aozasa O., Shimidzu Y., Ochiai F., Kida T., Nishi M., Miyata H. Comparison of polybrominated diphenyl ethers in fish, vegetables, and meats and levels in human milk of nursing women in Japan. Chemosphere. (2002). Feb; 46(5):689–96.
289. Paepke O, Herrmann T. Polybrominated diphenylethers (PBDEs) in fish samples or various origin. Organohalogen Compounds. Vol 66 (2004).
290. Schlabach M., Fjeld E., Brevik E. Polybrominated diphenylethers and other persistent organic pollutants in Norwegian freshwater fish. Brominated Flame Retardant Workshop (BFR). Stockholm, 371–374. (2001).
291. Sellstrom U. (1996). Polybrominated diphenyl ethers in the Swedish environment. Fil. lic. Thesis, Stockholm University. Stockholm, Sweden.
292. Sellstrom U., Jansson B., Kierkegaard A., De Wit C., Odsjo T., Olsson M. (1993). Polybrominated diphenyl ethers (PBDE) in biological samples from the Swedish environment.
293. Strandman T., Koistinen J., Kiviranta H., Vuorinen P.J., Tuomisto J., Vartiainen T. (1999). Levels of some polybrominated diphenyl ethers (PBDEs) in fish and human adipose tissue in Finland. Organohalogen Compd. 40: 355–358.
294. Tomy G.T., Budakowski W., Halldorson T., Whittle D.M., Keir M.J., Marvin C., MacInnis G., Alaee M. Biomagnification of alpha- and gamma-hexabromocyclododecane isomers in a Lake Ontario food web. Environ Sci Technol. (2004) Apr 15; 38(8):2298–303.
295. Zennegg M., Kohler M., Gerecke A.C., Schmid P. Polybrominated diphenyl ethers in whitefish from Swiss lakes and farmed rainbow trout. Chemosphere. (2003). May; 51(7):545–53.
296. Bakker E.C., Ghys A.J.A., Kester A.D.M., Vles J.S.H., Dubas J.S., Blanco C.E., Hornstra G. (2003). Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 y of age. Eur. J. Clin. Nutr. 57: 89–95.
297. Berger A., Mutch D.M., German J.B., Roberts M.A. (2002). Dietary effects of arachidonaterich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids in Health and Diseases, Vol. 1.
298. Burdge G.C., Jones A.E., Wootton S.A. (2002). Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 88: 355–363.
299. Burdge G.C. and Wootton S.A. (2002). Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 88: 411–420.
300. Carnielli V.P., Wattimena D.J.L., Luijendijk I.H.T., Boerlage A., Degenhart H.J., Sauer P.J.J. (1996). The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids. Pediatr. Res. 40: 169–174.
301. Chambaz J., Ravel D., Manier M.C., Pepin D., Mulliez N., Bereziat G. (1985). Essential fatty acids interconversion in the human fetal liver. Biol. Neonate 47: 136–140.
302. Clandinin M.T., Chappell J.E., Heim T., Swyer P.R., Chance G.W. (1981). Fatty acid accretion in fetal and neonatal liver: implications for fatty acid requirements. Early Hum. Dev. 5: 7–14.
303. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. (1980). Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum. Dev. 4: 121–129.
304. Cooper A.L., Gibbons L., Horan M.A., Little R.A., Rothwell N.J. (1993). Effect of dietary fish oil supplementation on fever and cytokine production in human volunteers. Clin. Nutr. 12: 321–328.
305. De Groot R.H.M., Hornstra G., Van Houwelingen A.C., Roumen F. (2004). Effect of α-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome. Am J Clin Nutr 79: 251–260.
306. Emken E.A., Adlof R.O., Duval S.M., Nelson G.J. (1999). Effect of dietary docosahexaenoic acid on desaturation and uptake in vivo of isotope-labeled oleic, linoleic, and linolenic acids by male subjects. Lipids 34: 785–791.
307. FSA (UK Food Standards Agency) (2004a). Advice on fish consumption: benefits & risks. Scientific Advisory Committee on Nutrition and Committee on toxicity. Published at: www.food.gov.uk/multimedia/pdfs/fishreport2004full.pdf.
308. Gallin J.L., Kaye D., O'Leary W.M. (1969). Serum lipids in infection. N. Engl. J. Med. 281: 1081–1086.
309. Ghys A., Bakker E., Hornstra G., Van den Hout M. (2002). Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum. Dev. 69: 83–90.
310. Gronn M., Christensen E., Hagve T.A., Christophersen B.O. (1992). Effects of dietary purified eicosapentaenoic acid (20:5(n-3)) and docosahexaenoic acid (22:6(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cells. Biochim. Biophys. Acta 1125: 35–43.
311. Helland I.B., Smith L., Saarem K., Saugstad O.D., Drevon C.A. (2003). Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 111:39–44.
312. Hornstra G. (1992). Essential fatty acids, pregnancy, and pregnancy complications: a roundtable discussion. In: Essential Fatty Acids and Eicosanoids. Sinclair A, Gibson R (eds). Champaign, IL: American Oil Chemists' Society, pp. 177–182.
313. Hornstra G. (2005). Essential fatty acids during pregnancy. Impact on mother and child. In: The Impact of Maternal Nutrition on the Offspring. Hornstra G, Uauy R, Yang X (eds) Nestlé Nutrition Workshop Series Pediatric Program, Vol. 55, pp. 83–100.
314. Innis S.M. (2003). Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J. Pediatr. 143: S1–S8.
315. Jump D.B. (2002). Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr. Opin. Lipidol. 13: 155–164.
316. Jump D.B. and Clarke S.D. (1999). Regulation of gene expression by dietary fat. Annu. Rev. Nutr. 19: 63–90.
317. Kelley D.S. (2001). Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition 17: 669–673.
318. Kelley D.S., Taylor P.C., Nelson G.J., Mackey B.E. (1998). Dietary docosahexaenoic acid and immuno competence in young healthy men. Lipids 33: 559–566.
319. Kelley D.S., Taylor P.C., Nelson G.J., Schmidt P.C., Ferretti A., Erickson K.L., Yu R., Chandra R.K., Mackey B.E. (1999). Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 34: 317–324.
320. Lee T.H., Hoover R.L., Williams J.D., Sperling R.I., Ravalese J. 3rd, Spur B.W., Robinson D.R., Corey E.J., Lewis R.A., Austen K.F. (1985). Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N. Engl. J. Med. 312: 1217–1224.
321. Markovic O., O'Reilly G., Fussell H.M., Turner S.J., Calder P.C., Howell W.M., Grimble R.F. (2004). Role of single nucleotide polymorphisms of pro-inflammatory cytokine genes in the relationship between serum lipids and inflammatory parameters, and the lipid-lowering effect of fish oil in healthy males. Clin. Nutr. 23: 1084–1095.
322. Nossen J.O., Rustan A.C., Gloppestad S.H., Malbakken S., Drevon C.A. (1986). Eicosapentaenoic acid inhibits synthesis and secretion of triacylglycerols by cultured rat hepatocytes. Biochim. Biophys. Acta 879: 56–65.
323. Otto S.J., Van Houwelingen A.C., Badart-Smook A., Hornstra G. (2001a). Changes in the maternal essential fatty acid profile during early pregnancy and the relation of the profile to diet. Am. J. Clin. Nutr. 73: 302–307.
324. Otto S.J., Van Houwelingen A.C., Badart-Smook A., Hornstra G. (2001b). Comparison of the peripartum and postpartum phospholipid polyunsaturated faty acid profiles of lactating and nonlactating women. Am J Clin Nutr 73: 1074–1079.
325. Roche H.M. and Gibney M.J. (2000). Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am. J. Clin. Nutr. 71: 232S–237S.
326. Rodriguez A., Sarda P., Nessmann C., Boulot P., Poisson J.P., Leger C.L., Descomps B. (1998): Fatty acid desaturase activities and polyunsaturated fatty acid composition in human fetal liver between the seventeenth and thirty-sixth gestational weeks. Am. J. Obstet. Gynecol. 179: 1063–1070.
327. Salem N., Wegher B., Mena P., Uauy R. (1996). Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc. Natl. Acad. Sci. USA 93: 49–54.
328. Samra J.S., Summers L.K.M., Frayn K.N. (1996). Sepsis and fat metabolism. Br. J. Surg. 83: 1186–1196.
329. Sauerwald T.U., Hachey D.L., Jensen C.L., Chen H., Anderson R.E., Heird W.C. (1997). Intermediates in endogenous synthesis of C22:6omega3 and C20:4omega6 by term and preterm infants. Pediatr. Res. 41: 183–187.
330. Schmidt E.B., Pedersen J.O., Ekelund S., Grunnet N., Jersild C., Dyerberg J. (1989). Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis 77: 53–57.
331. Uauy R., Calderon F., Mena P. (2001). Essential fatty acids in somatic growth and brain development. World Rev. Nutr. Diet. 89: 134–160.
332. Uauy R., Mena P., Wegher B., Nieto S., Salem N. Jr. (2000). Long chain polyunsaturated fatty acid formation in neonates: effect of gestational age and intrauterine growth. Pediatr. Res. 47: 127–135.
333. Van Houwelingen A.C., Sorensen J.D., Hornstra G., Simonis M.M., Olsen S.F., Secher N.J. (1995). Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy. Brit J Nutr 74: 723–731.
334. Willumsen N., Skorve J., Hexeberg S., Rustan A.C., Berge R.K. (1993). The hypotriglyceridemic effect of eicosapentaenoic acid in rats is reflected in increased mitochondrial fatty acid oxidation followed by diminished lipogenesis. Lipids 28: 683–690.
335. Wong S., Reardon M., Nestel P. (1985): Reduced triglyceride formation from long-chain polyenoic fatty acids in rat hepatocytes. Metabolism 34: 900–905.